Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$1.61 - $2.54 $31,813 - $50,190
-19,760 Reduced 57.13%
14,827 $26,000
Q2 2023

Aug 14, 2023

SELL
$1.14 - $1.95 $76,185 - $130,316
-66,829 Reduced 65.9%
34,587 $64,000
Q1 2023

May 15, 2023

SELL
$1.2 - $2.19 $1,866 - $3,405
-1,555 Reduced 1.51%
101,416 $134,000
Q4 2022

Feb 14, 2023

BUY
$1.63 - $3.52 $167,842 - $362,457
102,971 New
102,971 $174,000
Q4 2021

Feb 14, 2022

SELL
$8.31 - $14.92 $831,000 - $1.49 Million
-100,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$9.15 - $13.28 $915,000 - $1.33 Million
100,000 New
100,000 $1.15 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.